1. Kojima, M. et al. Epidemiological characteristics of rheumatoid arthritis in Japan: Prevalence estimates using a nationwide population-based questionnaire survey. Mod. Rheumatol. 30, 941–947 (2020).
2. Smolen, J. S., Aletaha, D., Grisar, J. C., Stamm, T. A. & Sharp, J. T. Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials. Ann. Rheum. Dis. 69, 1058–1064 (2010).
3. Rosenstein, E. D. & Caldwell, J. R. Trace elements in the treatment of rheumatic conditions. Rheum. Dis. Clin. North Am. 25, 929–935 (1999).
4. Lipsky, P. E. Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphoctye proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes. J. Clin. Invest. 73, 53–65 (1984).
5. Williams, H. J. et al. Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical Trial. Arthritis Rheum. 28, 721–730 (1985).
6. Elliott, M. J. et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344, 1105–1110 (1994).
7. Nielen, M. M. J. et al. Specific Autoantibodies Precede the Symptoms of Rheumatoid Arthritis: A Study of Serial Measurements in Blood Donors. Arthritis Rheum. 50, 380–386 (2004).
8. Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376–381 (2014).
9. Klarenbeek, P. L. et al. Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune disease. Ann. Rheum. Dis. 71, 1088–1093 (2012).
10. Hirahara, K. & Nakayama, T. CD4+ T-cell subsets in inflammatory diseases: Beyond the Th1/Th2 paradigm. Int. Immunol. 28, 163–171 (2016).
11. Szabo, S. J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655–669 (2000).
12. Zheng, W. P. & Flavell, R. A. The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells. Cell 89, 587–596 (1997).
13. Ivanov, I. I. et al. The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells. Cell 126, 1121–1133 (2006).
14. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. J. Immunol. 198, 981–985 (2017).
15. Johnston, R. J. et al. Bcl6 and Blimp-1 Are Reciprocal and Antagonistic Regulators of T Follicular Helper Cell Differentiation. Science (80-. ). 325, 1006–1010 (2009).
16. Kawashima, M. & Miossec, P. mRNA quantification of T-bet, GATA-3, IFN-γ, and IL-4 shows a defective Th1 immune response in the peripheral blood from rheumatoid arthritis patients: Link with disease activity. J. Clin. Immunol. 25, 209–214 (2005).
17. Leipe, J. et al. Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum. 62, 2876–2885 (2010).
18. Chu, C. Q., Song, Z., Mayton, L., Wu, B. & Wooley, P. H. IFNγ deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vβ6 and Vβ8 in arthritic joints. Ann. Rheum. Dis. 62, 983–990 (2003).
19. Guedez, Y. B. et al. Genetic ablation of interferon-γ up-regulates interleukin-1β expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum. 44, 2413–2424 (2001).
20. Chu, C. Q., Swart, D., Alcorn, D., Tocker, J. & Elkon, K. B. Interferon-γ regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17. Arthritis Rheum. 56, 1145–1151 (2007).
21. Corneth, O. B. J. et al. Absence of interleukin-17 receptor a signaling prevents autoimmune inflammation of the joint and leads to a Th2-like phenotype in collagen-induced arthritis. Arthritis Rheumatol. 66, 340–349 (2014).
22. Kondo, Y. et al. Overexpression of T-bet gene regulates murine autoimmune arthritis. Arthritis Rheum. 64, 162–172 (2012).
23. Yokosawa, M. et al. T-bet over-expression regulates aryl hydrocarbon receptor-mediated T helper type 17 differentiation through an interferon (IFN)γ independent pathway. Clin. Exp. Immunol. 188, 22–35 (2017).
24. Bendele, A. et al. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: Comparison of efficacy in animal models with human clinical data. Arthritis Rheum. 42, 498–506 (1999).
25. Nakae, S., Nambu, A., Sudo, K. & Iwakura, Y. Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice. J. Immunol. 171, 6173–6177 (2003).
26. Morgan, M. E. et al. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum. 48, 1452–1460 (2003).
27. Morgan, M. E. et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum. 52, 2212–2221 (2005).
28. Ryu, J. G. et al. Treatment of IL-21R-Fc control autoimmune arthritis via suppression of STAT3 signal pathway mediated regulation of the Th17/Treg balance and plasma B cells. Immunol. Lett. 163, 143–150 (2015).
29. Leavenworth, J. W., Wang, X., Schellack, C., Spee, P. & Cantor, H. Mobilization of natural killer cells inhibits development of collagen-induced arthritis. Proc. Natl. Acad. Sci. U. S. A. 108, 14584–14589 (2011).
30. Plank, M. W. et al. Th22 Cells Form a Distinct Th Lineage from Th17 Cells In Vitro with Unique Transcriptional Properties and Tbet-Dependent Th1 Plasticity. J. Immunol. 198, 2182–2190 (2017).
31. Ciofani, M. et al. A validated regulatory network for Th17 cell specification. Cell 151, 289–303 (2012).
32. Zhou, L. & Littman, D. R. Transcriptional regulatory networks in Th17 cell differentiation. Curr. Opin. Immunol. 21, 146–152 (2009).
33. Stadhouders, R., Lubberts, E. & Hendriks, R. W. A cellular and molecular view of T helper 17 cell plasticity in autoimmunity. J. Autoimmun. 87, 1–15 (2018).
34. Zhang, H. et al. An IL-27-Driven Transcriptional Network Identifies Regulators of IL-10 Expression across T Helper Cell Subsets. Cell Rep. 33, 108433 (2020).
35. McGeachy, M. J. et al. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nat. Immunol. 8, 1390–1397 (2007).
36. Sun, M. et al. RORγt Represses IL-10 Production in Th17 Cells To Maintain Their Pathogenicity in Inducing Intestinal Inflammation. J. Immunol. 202, 79–92 (2019).
37. Lee, Y. et al. Induction and molecular signature of pathogenic T H 17 cells. Nat. Immunol. 13, 991–999 (2012).
38. Cho, Y. G., Cho, M. La, Min, S. Y. & Kim, H. Y. Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmun. Rev. 7, 65–70 (2007).
39. Mitsdoerffer, M. et al. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc. Natl. Acad. Sci. U. S. A. 107, 14292–14297 (2010).
40. Nakayamada, S. et al. Early Th1 Cell Differentiation Is Marked by a Tfh Cell-like Transition. Immunity 35, 919–931 (2011).
41. Svensson, L., Nandakumar, K. S., Johansson, Å., Jansson, L. & Holmdahl, R. IL-4-deficient mice develop less acute but more chronic relapsing collagen-induced arthritis. Eur. J. Immunol. 32, 2944–2953 (2002).
42. Gracie, J. A. & Bradley, J. A. Interleukin-12 induces interferon-γ-dependent switching of IgG alloantibody subclass. Eur. J. Immunol. 26, 1217–1221 (1996).
43. Schnare, M. et al. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2, 947–950 (2001).
44. Kaplan, M. H., Sun, Y.-L., Hoey, T. & Grusby, M. J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382, 174–177 (1996).
45. Levine, A. G. et al. Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature 546, 421–425 (2017).
46. Yang, X. O. et al. T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ. Immunity 28, 29–39 (2008).
47. Zhang, F., Meng, G. & Strober, W. Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat. Immunol. 9, 1297–1306 (2008).
48. Lazarevic, V. et al. T-bet represses TH 17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt. Nat. Immunol. 12, 96–104 (2011).
49. Fossiez, F. et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183, 2593–2603 (1996).
50. Chabaud, M., Page, G. & Miossec, P. Enhancing Effect of IL-1, IL-17, and TNF-α on Macrophage Inflammatory Protein-3α Production in Rheumatoid Arthritis: Regulation by Soluble Receptors and Th2 Cytokines. J. Immunol. 167, 6015–6020 (2001).
51. Huber, A. R., Kunkel, S. L., Todd, R. F. & Weiss, S. J. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science (80-. ). 254, 99–102 (1991).
52. Hirota, K. et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204, 2803–2812 (2007).
53. Sato, K. et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203, 2673–2682 (2006).
54. Kotake, S. et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis Find the latest version : IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. 103, 1345–1352 (1999).
55. Wang, J. et al. Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells. J. Clin. Invest. 116, 414–421 (2006).
56. Huber, K., Sármay, G. & Kövesdi, D. MZ B cells migrate in a T-bet dependent manner and might contribute to the remission of collagen-induced arthritis by the secretion of IL-10. Eur. J. Immunol. 46, 2239–2246 (2016).
論文の公開元へ
